

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.65952597 |
| 2 | DNA deamination (GO:0045006) | 7.61559415 |
| 3 | cytidine catabolic process (GO:0006216) | 7.06921233 |
| 4 | cytidine deamination (GO:0009972) | 7.06921233 |
| 5 | cytidine metabolic process (GO:0046087) | 7.06921233 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.09520178 |
| 7 | sequestering of actin monomers (GO:0042989) | 5.29987613 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 4.83166662 |
| 9 | positive regulation of defense response to virus by host (GO:0002230) | 4.34209243 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.32635882 |
| 11 | response to pheromone (GO:0019236) | 4.13950880 |
| 12 | negative T cell selection (GO:0043383) | 3.99667262 |
| 13 | regulation of activation of Janus kinase activity (GO:0010533) | 3.93572040 |
| 14 | actin nucleation (GO:0045010) | 3.88187197 |
| 15 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.84293512 |
| 16 | platelet dense granule organization (GO:0060155) | 3.73025668 |
| 17 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.66311149 |
| 18 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.60300542 |
| 19 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.57915100 |
| 20 | response to interleukin-15 (GO:0070672) | 3.57075615 |
| 21 | DNA demethylation (GO:0080111) | 3.54490042 |
| 22 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52179031 |
| 23 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49654493 |
| 24 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.48960007 |
| 25 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.48960007 |
| 26 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.48960007 |
| 27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.48938052 |
| 28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.48938052 |
| 29 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.47862634 |
| 30 | proteasome assembly (GO:0043248) | 3.41733407 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.38761228 |
| 32 | positive T cell selection (GO:0043368) | 3.38463711 |
| 33 | interferon-gamma production (GO:0032609) | 3.35676642 |
| 34 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.32869231 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31769491 |
| 36 | negative regulation of ligase activity (GO:0051352) | 3.31448267 |
| 37 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.31448267 |
| 38 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.31226753 |
| 39 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.31226753 |
| 40 | protein neddylation (GO:0045116) | 3.31002297 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.26149603 |
| 42 | cell wall macromolecule catabolic process (GO:0016998) | 3.21118328 |
| 43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.18937801 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 3.18937801 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18758050 |
| 46 | cell wall macromolecule metabolic process (GO:0044036) | 3.16906462 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13913296 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12427224 |
| 49 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.10745036 |
| 50 | cellular defense response (GO:0006968) | 3.09710615 |
| 51 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.09627363 |
| 52 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.09115056 |
| 53 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.09115056 |
| 54 | positive regulation of cell killing (GO:0031343) | 3.07923619 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.05330116 |
| 56 | regulation of memory T cell differentiation (GO:0043380) | 3.04810247 |
| 57 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03883828 |
| 58 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.02733112 |
| 59 | protein deneddylation (GO:0000338) | 3.02659497 |
| 60 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.02279124 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99308522 |
| 62 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93728689 |
| 63 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.93090438 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.92690829 |
| 65 | regulation of cell killing (GO:0031341) | 2.92335440 |
| 66 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.90386177 |
| 67 | regulation of defense response to virus by host (GO:0050691) | 2.86972717 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.84937804 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.84937804 |
| 70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.84382574 |
| 71 | negative thymic T cell selection (GO:0045060) | 2.82850256 |
| 72 | positive regulation of ligase activity (GO:0051351) | 2.82526491 |
| 73 | positive regulation of T cell mediated immunity (GO:0002711) | 2.80626172 |
| 74 | negative regulation of mast cell activation (GO:0033004) | 2.78142909 |
| 75 | DNA dealkylation (GO:0035510) | 2.74739680 |
| 76 | cullin deneddylation (GO:0010388) | 2.72944694 |
| 77 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71094082 |
| 78 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.70901572 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.69791088 |
| 80 | positive regulation of cell cycle arrest (GO:0071158) | 2.69647495 |
| 81 | microtubule depolymerization (GO:0007019) | 2.69200865 |
| 82 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.66999245 |
| 83 | T cell migration (GO:0072678) | 2.66897260 |
| 84 | ubiquinone metabolic process (GO:0006743) | 2.64045464 |
| 85 | negative regulation by host of viral transcription (GO:0043922) | 2.63621568 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.62038002 |
| 87 | protein complex biogenesis (GO:0070271) | 2.60887275 |
| 88 | dopamine transport (GO:0015872) | 2.60325139 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.59947506 |
| 90 | regulation of cellular amine metabolic process (GO:0033238) | 2.59035700 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 2.58261510 |
| 92 | S-adenosylmethionine metabolic process (GO:0046500) | 2.56510088 |
| 93 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.56123830 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.55326255 |
| 95 | metallo-sulfur cluster assembly (GO:0031163) | 2.54524558 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 2.54524558 |
| 97 | T cell receptor signaling pathway (GO:0050852) | 2.54193523 |
| 98 | ubiquinone biosynthetic process (GO:0006744) | 2.52774050 |
| 99 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.52669943 |
| 100 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.52453033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.47084469 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.34524288 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.15256479 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.67292832 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.58587681 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11725229 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83954364 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76947638 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74398087 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64981723 |
| 11 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.59629658 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58160162 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.46487939 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.44611506 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.39808004 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39177692 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.28414488 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.26735143 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19963811 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18373992 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.12271700 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.07146749 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.06052303 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.00056068 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97543681 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.92659254 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.91347185 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.88193404 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.84463063 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.76074150 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.73629470 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72734337 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.72133172 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63848050 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62812980 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61465236 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61129172 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59338948 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.58924557 |
| 40 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.54517091 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51432011 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49530102 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48584175 |
| 44 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.47694601 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45142924 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43041122 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41592446 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39287001 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.38453360 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37535135 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32966282 |
| 52 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29133984 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28999722 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.27557848 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26798073 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26284413 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25439515 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24924312 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21453620 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19457683 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18520928 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18426373 |
| 63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16612103 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16499731 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15880301 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14985362 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13617492 |
| 68 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07116257 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06790885 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05084469 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.04771638 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04594698 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04110932 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03985442 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03195134 |
| 76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02970854 |
| 77 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02604004 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 1.01963759 |
| 79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.00891888 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00031332 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98834633 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 0.96902449 |
| 83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95503087 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.95368904 |
| 85 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94939540 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.94218734 |
| 87 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92762720 |
| 88 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91960831 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91466671 |
| 90 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90665951 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90404340 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90023686 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89796252 |
| 94 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.89730446 |
| 95 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89037857 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88960105 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88960105 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88824843 |
| 99 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.87892010 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86724408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.72863081 |
| 2 | MP0003786_premature_aging | 3.42277343 |
| 3 | MP0009785_altered_susceptibility_to | 2.83486790 |
| 4 | MP0002736_abnormal_nociception_after | 2.51386852 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.41651793 |
| 6 | MP0002102_abnormal_ear_morphology | 2.32115537 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.31873242 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.26155221 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.19303806 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.14352930 |
| 11 | MP0001800_abnormal_humoral_immune | 2.12810075 |
| 12 | MP0003878_abnormal_ear_physiology | 2.10341973 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.10341973 |
| 14 | MP0000685_abnormal_immune_system | 2.07513253 |
| 15 | MP0008995_early_reproductive_senescence | 2.05420225 |
| 16 | MP0003011_delayed_dark_adaptation | 2.03632458 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 2.03168605 |
| 18 | MP0003724_increased_susceptibility_to | 2.01086354 |
| 19 | MP0003866_abnormal_defecation | 1.98527790 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.95352873 |
| 21 | MP0005646_abnormal_pituitary_gland | 1.94946502 |
| 22 | MP0002723_abnormal_immune_serum | 1.94775912 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.93628852 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.91739113 |
| 25 | MP0006072_abnormal_retinal_apoptosis | 1.91640352 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.91223753 |
| 27 | MP0001819_abnormal_immune_cell | 1.87375487 |
| 28 | MP0008872_abnormal_physiological_respon | 1.77742812 |
| 29 | MP0002006_tumorigenesis | 1.75727163 |
| 30 | MP0004147_increased_porphyrin_level | 1.73602152 |
| 31 | MP0001529_abnormal_vocalization | 1.68839236 |
| 32 | MP0005025_abnormal_response_to | 1.65995863 |
| 33 | MP0003646_muscle_fatigue | 1.61480173 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.57189470 |
| 35 | MP0008058_abnormal_DNA_repair | 1.54690861 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.52520875 |
| 37 | MP0008789_abnormal_olfactory_epithelium | 1.52427012 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.49002902 |
| 39 | MP0001790_abnormal_immune_system | 1.48661913 |
| 40 | MP0005387_immune_system_phenotype | 1.48661913 |
| 41 | MP0002398_abnormal_bone_marrow | 1.48241494 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.44139041 |
| 43 | MP0000716_abnormal_immune_system | 1.41062822 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.30933033 |
| 45 | MP0006054_spinal_hemorrhage | 1.28124985 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.26114442 |
| 47 | MP0005253_abnormal_eye_physiology | 1.24614326 |
| 48 | MP0002405_respiratory_system_inflammati | 1.22309682 |
| 49 | MP0002722_abnormal_immune_system | 1.18490623 |
| 50 | MP0006082_CNS_inflammation | 1.16644803 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.16472620 |
| 52 | MP0001905_abnormal_dopamine_level | 1.16340847 |
| 53 | MP0003718_maternal_effect | 1.15687270 |
| 54 | MP0002429_abnormal_blood_cell | 1.15656046 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.15213224 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.14400654 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.14035927 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.12174747 |
| 59 | MP0003693_abnormal_embryo_hatching | 1.09934668 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.05715177 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02230691 |
| 62 | MP0003195_calcinosis | 1.00861921 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.00072886 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 0.97968226 |
| 65 | MP0009764_decreased_sensitivity_to | 0.96946878 |
| 66 | MP0008877_abnormal_DNA_methylation | 0.96639155 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.95938802 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95839831 |
| 69 | MP0005410_abnormal_fertilization | 0.93475653 |
| 70 | MP0010094_abnormal_chromosome_stability | 0.93342453 |
| 71 | MP0001919_abnormal_reproductive_system | 0.93204546 |
| 72 | MP0002019_abnormal_tumor_incidence | 0.90327362 |
| 73 | MP0008469_abnormal_protein_level | 0.89179044 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.88532902 |
| 75 | MP0001984_abnormal_olfaction | 0.87492986 |
| 76 | MP0001873_stomach_inflammation | 0.87248114 |
| 77 | MP0002419_abnormal_innate_immunity | 0.87190099 |
| 78 | MP0004885_abnormal_endolymph | 0.85955634 |
| 79 | MP0005389_reproductive_system_phenotype | 0.85913395 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.85907621 |
| 81 | MP0004957_abnormal_blastocyst_morpholog | 0.85019896 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.84444890 |
| 83 | MP0005423_abnormal_somatic_nervous | 0.81625381 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.79308569 |
| 85 | MP0001542_abnormal_bone_strength | 0.79170043 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.77267557 |
| 87 | MP0005499_abnormal_olfactory_system | 0.77267557 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.77172353 |
| 89 | MP0009763_increased_sensitivity_to | 0.75983071 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.75842618 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.75758132 |
| 92 | MP0003448_altered_tumor_morphology | 0.71964438 |
| 93 | MP0001188_hyperpigmentation | 0.71670170 |
| 94 | MP0001853_heart_inflammation | 0.67690972 |
| 95 | MP0004142_abnormal_muscle_tone | 0.67317628 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.66146832 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.64734749 |
| 98 | MP0004947_skin_inflammation | 0.64155005 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.62472311 |
| 100 | MP0001119_abnormal_female_reproductive | 0.62085949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.58331802 |
| 2 | IgG deficiency (HP:0004315) | 4.54374977 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.23267379 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.99614448 |
| 5 | Stomatitis (HP:0010280) | 3.55751469 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.46951074 |
| 7 | Aplastic anemia (HP:0001915) | 3.26048521 |
| 8 | Combined immunodeficiency (HP:0005387) | 3.25311386 |
| 9 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.24959545 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.23171859 |
| 11 | Abnormality of T cells (HP:0002843) | 3.19685131 |
| 12 | Chronic diarrhea (HP:0002028) | 3.16181723 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.13782550 |
| 14 | Methylmalonic acidemia (HP:0002912) | 3.11438080 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01935458 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.01337039 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 2.88093514 |
| 18 | Increased CSF lactate (HP:0002490) | 2.84243781 |
| 19 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.83428145 |
| 20 | Methylmalonic aciduria (HP:0012120) | 2.82545796 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 2.79482841 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 2.74307964 |
| 23 | Hepatic necrosis (HP:0002605) | 2.73464950 |
| 24 | Pancreatic cysts (HP:0001737) | 2.73252624 |
| 25 | Hypoproteinemia (HP:0003075) | 2.71776267 |
| 26 | Abnormality of the prostate (HP:0008775) | 2.69911212 |
| 27 | Renal cortical cysts (HP:0000803) | 2.67357757 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67100999 |
| 29 | Pancytopenia (HP:0001876) | 2.62410108 |
| 30 | IgM deficiency (HP:0002850) | 2.60160428 |
| 31 | Oral leukoplakia (HP:0002745) | 2.49975798 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.48498979 |
| 33 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47437519 |
| 34 | Increased serum lactate (HP:0002151) | 2.46547288 |
| 35 | Thyroiditis (HP:0100646) | 2.45985198 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.45800432 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.43375594 |
| 38 | Abnormality of eosinophils (HP:0001879) | 2.41014415 |
| 39 | Fused cervical vertebrae (HP:0002949) | 2.40398715 |
| 40 | Prostate neoplasm (HP:0100787) | 2.30203170 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.27119807 |
| 42 | Myositis (HP:0100614) | 2.26009147 |
| 43 | Pendular nystagmus (HP:0012043) | 2.25428810 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.23211634 |
| 45 | Concave nail (HP:0001598) | 2.20285057 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.19224884 |
| 47 | Optic neuritis (HP:0100653) | 2.19224884 |
| 48 | Neonatal respiratory distress (HP:0002643) | 2.17967994 |
| 49 | Hyperglycinemia (HP:0002154) | 2.17769127 |
| 50 | Muscle fiber atrophy (HP:0100295) | 2.13957563 |
| 51 | Lactic acidosis (HP:0003128) | 2.13226037 |
| 52 | True hermaphroditism (HP:0010459) | 2.11948616 |
| 53 | Hypoplasia of the fovea (HP:0007750) | 2.10793472 |
| 54 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.10793472 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08510717 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08510717 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.06251448 |
| 58 | Acute encephalopathy (HP:0006846) | 2.06205453 |
| 59 | Hypoplasia of the uterus (HP:0000013) | 2.05900345 |
| 60 | Abnormality of the fovea (HP:0000493) | 2.04054068 |
| 61 | Joint swelling (HP:0001386) | 2.03542452 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03092874 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03092874 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.01209942 |
| 65 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00809171 |
| 66 | Increased muscle lipid content (HP:0009058) | 2.00690831 |
| 67 | Pancreatic fibrosis (HP:0100732) | 1.99975262 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98469100 |
| 69 | Progressive inability to walk (HP:0002505) | 1.97488380 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 1.97035422 |
| 71 | Lymphopenia (HP:0001888) | 1.96271473 |
| 72 | Keratoconjunctivitis (HP:0001096) | 1.96120571 |
| 73 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.95602574 |
| 74 | Unilateral renal agenesis (HP:0000122) | 1.94448823 |
| 75 | Dicarboxylic aciduria (HP:0003215) | 1.94072320 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94072320 |
| 77 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93311913 |
| 78 | Decreased central vision (HP:0007663) | 1.92924688 |
| 79 | Cerebral edema (HP:0002181) | 1.92866213 |
| 80 | Cerebral palsy (HP:0100021) | 1.92714539 |
| 81 | Synostosis involving the elbow (HP:0003938) | 1.90318224 |
| 82 | Humeroradial synostosis (HP:0003041) | 1.90318224 |
| 83 | Pustule (HP:0200039) | 1.89453703 |
| 84 | Optic disc pallor (HP:0000543) | 1.86627510 |
| 85 | Carpal bone hypoplasia (HP:0001498) | 1.85768760 |
| 86 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84429384 |
| 87 | Exertional dyspnea (HP:0002875) | 1.84319679 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.83300785 |
| 89 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81008682 |
| 90 | Encephalitis (HP:0002383) | 1.79472836 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.79407703 |
| 92 | Lissencephaly (HP:0001339) | 1.78262133 |
| 93 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77225903 |
| 94 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77172609 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 1.76068867 |
| 96 | Brittle hair (HP:0002299) | 1.76056638 |
| 97 | Abnormality of renal resorption (HP:0011038) | 1.75928063 |
| 98 | Progressive microcephaly (HP:0000253) | 1.74463230 |
| 99 | Exercise intolerance (HP:0003546) | 1.73950172 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 1.73805891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.23796440 |
| 2 | MAP4K2 | 4.13623230 |
| 3 | KDR | 3.62932967 |
| 4 | VRK2 | 2.99035423 |
| 5 | TESK2 | 2.91558436 |
| 6 | TAOK3 | 2.78801351 |
| 7 | STK16 | 2.73623297 |
| 8 | BCKDK | 2.32330682 |
| 9 | NUAK1 | 2.15056714 |
| 10 | BUB1 | 2.12223377 |
| 11 | MAP4K1 | 2.00543946 |
| 12 | TLK1 | 1.91012140 |
| 13 | TIE1 | 1.89580172 |
| 14 | SRPK1 | 1.68706351 |
| 15 | ZAK | 1.65513648 |
| 16 | VRK1 | 1.61811520 |
| 17 | EIF2AK3 | 1.60226773 |
| 18 | NME1 | 1.56302292 |
| 19 | BCR | 1.48906324 |
| 20 | ADRBK2 | 1.47768015 |
| 21 | LIMK1 | 1.45836356 |
| 22 | WNK4 | 1.45388742 |
| 23 | MAPKAPK3 | 1.44043777 |
| 24 | ITK | 1.43607677 |
| 25 | IKBKE | 1.34429791 |
| 26 | FES | 1.34205452 |
| 27 | SYK | 1.29867584 |
| 28 | CSNK1G3 | 1.27822414 |
| 29 | GRK7 | 1.25736321 |
| 30 | GRK1 | 1.24213162 |
| 31 | TRIM28 | 1.23784778 |
| 32 | GRK6 | 1.23560016 |
| 33 | MAP3K14 | 1.23019247 |
| 34 | STK10 | 1.10222705 |
| 35 | TESK1 | 1.05812164 |
| 36 | MST4 | 1.05178174 |
| 37 | CSNK1A1L | 1.03496193 |
| 38 | TEC | 1.01810129 |
| 39 | CSNK1G2 | 1.01195357 |
| 40 | GRK5 | 1.00102054 |
| 41 | EIF2AK1 | 0.96100452 |
| 42 | DAPK1 | 0.95395816 |
| 43 | CSNK1G1 | 0.90174759 |
| 44 | EPHA3 | 0.89546498 |
| 45 | PRKCQ | 0.86704852 |
| 46 | TAF1 | 0.83679398 |
| 47 | STK39 | 0.82037681 |
| 48 | CCNB1 | 0.80528731 |
| 49 | TBK1 | 0.78700109 |
| 50 | MAP2K7 | 0.78181702 |
| 51 | PIK3CA | 0.75038504 |
| 52 | LCK | 0.74056744 |
| 53 | PASK | 0.73161101 |
| 54 | MAPKAPK5 | 0.73007830 |
| 55 | EIF2AK2 | 0.72737124 |
| 56 | PLK3 | 0.72689051 |
| 57 | IKBKB | 0.71366262 |
| 58 | MAPK13 | 0.66302503 |
| 59 | LYN | 0.65251149 |
| 60 | ZAP70 | 0.63362172 |
| 61 | TGFBR2 | 0.62987609 |
| 62 | RPS6KA5 | 0.60661774 |
| 63 | BTK | 0.60062967 |
| 64 | ERBB3 | 0.59285147 |
| 65 | OXSR1 | 0.57930072 |
| 66 | NEK2 | 0.57086182 |
| 67 | PLK2 | 0.56624700 |
| 68 | WNK3 | 0.54442524 |
| 69 | MOS | 0.52358999 |
| 70 | CSF1R | 0.51572576 |
| 71 | PINK1 | 0.50062411 |
| 72 | SIK3 | 0.48751383 |
| 73 | AURKA | 0.47075508 |
| 74 | FRK | 0.46728785 |
| 75 | MAP2K6 | 0.46044352 |
| 76 | IGF1R | 0.44568539 |
| 77 | DYRK3 | 0.43948569 |
| 78 | BMPR1B | 0.43133263 |
| 79 | PLK4 | 0.42828552 |
| 80 | INSRR | 0.42579998 |
| 81 | CSK | 0.40287790 |
| 82 | MUSK | 0.39993187 |
| 83 | AURKB | 0.39534492 |
| 84 | TSSK6 | 0.37174273 |
| 85 | PIM2 | 0.36878136 |
| 86 | PIM1 | 0.35377311 |
| 87 | NEK1 | 0.34130413 |
| 88 | HCK | 0.33949760 |
| 89 | MATK | 0.33041624 |
| 90 | ADRBK1 | 0.32882591 |
| 91 | CHUK | 0.32072590 |
| 92 | MAP3K4 | 0.31460808 |
| 93 | PLK1 | 0.31059230 |
| 94 | JAK3 | 0.30661833 |
| 95 | DAPK2 | 0.29738386 |
| 96 | CDC7 | 0.28245205 |
| 97 | MAPKAPK2 | 0.27776546 |
| 98 | INSR | 0.27186955 |
| 99 | ARAF | 0.27019859 |
| 100 | CSNK2A1 | 0.26617427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.16703358 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.89294447 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.80587645 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.78650065 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.54865799 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.46211249 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.23790911 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13878127 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10522037 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.01431907 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96437852 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.95324243 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91065212 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.87178493 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.80386784 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79666381 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73983747 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.73046316 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.50381620 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.48710581 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41281407 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38153888 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38105242 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38050902 |
| 25 | DNA replication_Homo sapiens_hsa03030 | 1.37706322 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34297763 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.33575904 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30366765 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29777936 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29513415 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24410604 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22829270 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21576552 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18106525 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17615327 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.15834557 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14218161 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13477733 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12035079 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11942800 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11131072 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09046063 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.05628896 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.03119058 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02839397 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00175651 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98691956 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97417019 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96998952 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96615638 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95528771 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94246784 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.92652748 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.90897257 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90098783 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89646569 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88700514 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.88322078 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87277350 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86176441 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.84896242 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.83305854 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83194830 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82135585 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81776852 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.77471947 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.76175854 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68324879 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67868545 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66341990 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65312673 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64459153 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61746365 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.61737395 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.61220513 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.58631074 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56142085 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54972869 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54540787 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 0.53846782 |
| 81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52272762 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45273586 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41999044 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41707473 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41407983 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40200359 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35739326 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34848908 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34183666 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33685155 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32971700 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32687028 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30000938 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.29443110 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26258010 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25772891 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25362467 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25100492 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23716842 |
| 100 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23044945 |

